"HB-adMSCs for the Treatment of Patients With Multiple Sclerosis"
Status:
ENROLLING_BY_INVITATION
Trial end date:
2027-01-01
Target enrollment:
Participant gender:
Summary
This protocol is part of a clinical study to evaluate efficacy and safety of multiple intravenous administrations of HB-adMSCs for the treatment of Multiple Sclerosis.